Mayo Clinic Hematology & Medical Oncology Practice Updates and Board Review Online Course 2025
$90
Secure checkoutEncrypted, private payment
Delivery Via Fast Download linkDownloadable Files from Google Drive
Easy accessDownload and learn without streaming
Email supportQuick help with questions
Mayo Clinic Hematology & Medical Oncology Practice Updates and Board Review Online Course 2025
Include: videos + pdf
Target Audience: clinicians, fellows, residents preparing for the ABIM certification exams or seeking practical updates for daily practice in hematology, oncology
Information:
Course opens: 08/28/2025
COURSE DIRECTORS: Kebede H. Begna, M.D., Tanios S. Bekaii-Saab, M.D., Naseema Gangat, M.B.B.S., Wilson I. Gonsalves, M.D., Thor R. Halfdanarson, M.D., Rami Manochakian, M.D., Sameer A. Parikh, M.B.B.S., and Kathryn J. Ruddy, M.D.
This online course offers up-to-date, practical information in hematology and medical oncology for immediate clinical use. It also provides high-yield content to help prepare for the ABIM initial and maintenance certification exams in both specialties.
This online course features repurposed content from the in-person Hematology & Medical Oncology Practice Updates and Board Review 2025 event.
Target Audience
This activity is appropriate for physicians and resident fellows.
Learning Objectives
- Recognize evidence-based practices for managing patients with bleeding and/or clotting disorders.
- Identify appropriate molecular tests, such as next-generation sequencing, for cancer diagnosis.
- Recognize how to incorporate the most current cancer treatment options, such as immunotherapy or targeted therapy, into clinical practice.
+ Topics:
| August 28, 2025 – August 29, 2028 | ||
| Duration | Lecture Title | Speaker(s) |
| 0:25:20 | Early Breast Cancer Locoregional Therapy | Tina Hieken, M.D. |
| 0:35:08 | HER2-Positive Breast Cancer | Pooja Advani, M.B.B.S., M.D. |
| 0:34:02 | Systemic Therapy for TNBC: Curative & Palliative | Roberto Leon Ferre, M.D. |
| 0:37:40 | Systemic Therapy for ER+/HER2 Breast Cancer Therapy | Tufia Haddad, M.D. |
| 0:31:21 | Management of Early-Stage Colorectal Cancer | Jeremy Jones, M.D. |
| 0:34:08 | Advanced Colorectal Cancer (CRC) | Tanios Bekaii-Saab, M.D. |
| 0:35:44 | Upper GI Cancer | Bassam Sonbol, M.D. |
| 0:29:30 | Hepatobiliary Cancers | Mitesh Borad, M.D. |
| 0:24:32 | Pancreatic Cancer 2025 | Robert McWilliams, M.D. |
| 0:31:10 | Update on Management of Early Stage NSCLC | Vinicius Ernani, M.D. |
| 0:37:26 | Advanced Stage IV NSCLC | Rami Manochakian, M.D. |
| 0:24:33 | Small Cell Lung Cancer | Kaushal Parikh, M.B.B.S. |
| 0:23:14 | Other Thoracic Malignancies | Konstantinos Leventakos, M.D., Ph.D. |
| 0:33:42 | Head and Neck Cancer | Katharine Price, M.D. |
| 0:21:24 | Neuro-Oncology | Alyx Porter, M.D. |
| 0:24:05 | Sarcoma | Steve Robinson, M.B.B.S. |
| 0:28:42 | Bladder Cancer Update | Parminder Singh, M.D. |
| 0:32:57 | RCC in 2025: What’s New for the Practicing Oncologist? | Yousef Zakharia |
| 0:26:04 | Germ Cell Cancers | Lance Pagliaro, M.D. |
| 0:33:24 | Prostate Cancer Board Review | Dan Childs, M.D. |
| 0:40:18 | Ovarian Cancer | Andrea Wahner Hendrickson, M.D. |
| 0:28:42 | Updates in Endocrine Malignancies | Mabel Ryder, M.D. |
| 0:26:59 | Hereditary Cancer Syndromes | Siddhartha Yadav, M.B.B.S., M.D. |
| 0:28:43 | Transfusion Medicine for Hematologist/Medical Oncologist | Jeffrey Winters, M.D. |
| 0:34:13 | Management of Thrombosis in Cancer | Aneel Ashrani, M.D., M.S. |
| 0:30:05 | Palliative Care and Symptom Management | Jacob Strand, M.D. |
| 0:23:25 | Hodgkin Lymphoma | Stephen Ansell, M.D., Ph.D. |
| 0:32:04 | Aggressive B-Cell Lymphoma | Grzegorz Nowakowski, M.D. |
| 0:24:53 | Chronic Lymphocytic Leukemia | Sameer Parikh, M.B.B.S. |
| 0:29:58 | Follicular and Mantle Cell Lymphoma Update | Thomas Witzig, M.D. |
| 0:25:11 | Other Indolent Non-Hodgkin Lymphomas | Thomas Habermann, M.D. |
| 0:20:55 | T cell lymphoma | Allison Rosenthal, D.O. |
| 0:26:33 | MGUS / Smoldering Myeloma | Angela Dispenzieri, M.D. |
| 0:30:59 | Newly Diagnosed Multiple Myeloma | Vivek Roy, M.D. |
| 0:38:27 | CAR-T in Myeloma | Yi Lin, M.D., Ph.D. |
| 0:25:53 | Waldenström’s Macroglobulinemia and Amyloidosis | Morie Gertz, M.D. |
| 0:34:40 | Myeloproliferative Neoplasms, Mastocytosis, and Eosinophilic Disorders | Ayalew Tefferi, M.D. |
| 0:30:10 | Myelodysplastic Syndromes and Bone Marrow Failure States – 2025 Updates | Mrinal Patnaik, M.B.B.S. |
| 0:19:22 | Chronic Myeloid Leukemia | Kebede Begna, M.D. |
| 0:23:12 | Acute Myeloid Leukemia | Naseema Gangat, M.B.B.S. |
| 0:33:38 | Update in Acute Lymphoblastic Leukemia | Mark Litzow, M.D. |
| 0:29:58 | Transplantation for Hematologic Disorders Including GVHD | William Hogan, M.B., B.Ch. |
| 0:27:08 | HLH Porphyrias / Acquired Thrombocytopenia (ITP) | Alexandra Wolanskyj-Spinner, M.D. |
| 0:26:46 | Platelet Disorders | Meera Sridharan, M.D., Ph.D. |
| 0:25:18 | Coagulation Factor Disorders: Molecular Basis, Inherited & Acquired Bleeding Disorders | Rajiv Pruthi, M.B.B.S. |
| 0:29:53 | Hemoglobinopathies | Ewa Wysokinska, M.D. |
| 0:26:00 | Nutritional Anemias and Iron Disorders | Ronald Go, M.D. |
| 0:28:54 | Immune Hemolytic Anemia | Surbhi Shah, M.B.B.S. |
| 28:00:23 Content Hours | ||
Related products
All Products
Oakstone Topics in Mammography 9th Edition 2025